BLT 0.00% 1.7¢ blis technologies limited ordinary shares

Ann: GENERAL: BLT: Preliminary Results for BLIS probiotic trial

  1. lightbulb Created with Sketch. 2
    • Release Date: 26/11/15 11:20
    • Summary: GENERAL: BLT: Preliminary Results for BLIS probiotic trial
    • Price Sensitive: No
    • Download Document  664B
    					BLT
    26/11/2015 11:20
    GENERAL
    NOT PRICE SENSITIVE
    REL: 1120 HRS BLIS Technologies Limited
    
    GENERAL: BLT: Preliminary Results for BLIS probiotic trial
    
    Preliminary results from a field trial in the Eastern Bay of Plenty using
    BLIS K12 probiotic presented to the Paediatric Society of New Zealand
    yesterday indicated that a one month course of BLIS K12 probiotic achieves a
    useful, greater decrease in both Group A Streptococcal (GAS) carriage and GAS
    sore throats than antibiotics alone.  Further analysis of the results are
    being undertaken and presented early next year.
    
    Peter Fennessy
    Chairman
    End CA:00274150 For:BLT    Type:GENERAL    Time:2015-11-26 11:20:37
    				
 
watchlist Created with Sketch. Add BLT (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.